Related Experiment Video
Updated: May 5, 2026

A Cell Culture Model for Studying the Role of Neuron-Glia Interactions in Ischemia
Published on: November 14, 2020
Neuroprotection by astrocytes in brain ischemia: importance of microRNAs
Yi-Bing Ouyang1, Lijun Xu1, Sibiao Yue2
1Department of Anesthesia, Stanford University School of Medicine, Stanford, CA 94305, USA.
Abstract:
Astrocytes have been shown to protect neurons and increase their survival in many pathological settings. Manipulating astrocyte functions is thus an important strategy to enhance neuronal survival and improve outcome following cerebral ischemia. Increasing evidence supports the involvement of microRNAs (miRNA), some of them being astrocyte-enriched, in the regulation of cerebral ischemia. This mini review will focus on several recently reported astrocyte-enriched miRNAs (miR-181 and miR-29 families and miR-146a), their validated targets, regional expression and effects on outcome after cerebral ischemia.
Insights
Manipulating astrocyte functions via astrocyte-enriched microRNAs (miRNAs) shows promise for improving outcomes after cerebral ischemia. This review highlights key miRNAs and their targets for enhancing neuronal survival.
Area of Science:
- Neuroscience
- Molecular Biology
- Cell Biology
Background:
- Astrocytes play a crucial role in neuroprotection and neuronal survival, particularly in pathological conditions like cerebral ischemia.
- Modulating astrocyte functions represents a promising therapeutic strategy to improve recovery after brain injury.
- MicroRNAs (miRNAs), including astrocyte-enriched ones, are increasingly recognized for their regulatory roles in cerebral ischemia.
Purpose of the Study:
- To review recent findings on astrocyte-enriched microRNAs (miRNAs) involved in cerebral ischemia.
- To discuss specific miRNAs, including miR-181, miR-29 families, and miR-146a, their validated targets, and regional expression.
- To evaluate the impact of these astrocyte-enriched miRNAs on outcomes following cerebral ischemia.
Main Methods:
- Literature review of recent scientific publications.
- Focus on astrocyte-enriched microRNAs (miRNAs) such as miR-181, miR-29 families, and miR-146a.
- Analysis of validated miRNA targets, regional expression patterns, and functional effects on cerebral ischemia outcomes.
Main Results:
- Several astrocyte-enriched miRNAs (miR-181, miR-29 families, miR-146a) are implicated in regulating cerebral ischemia.
- These miRNAs target key pathways involved in neuronal survival and inflammation.
- Specific miRNAs show distinct regional expression patterns and influence recovery after ischemic events.
Conclusions:
- Astrocyte-enriched miRNAs are significant regulators of neuronal survival and outcome in cerebral ischemia.
- Targeting these specific miRNAs offers a potential therapeutic avenue for treating ischemic stroke.
- Further research into miRNA-astrocyte interactions is warranted for developing novel neuroprotective strategies.

